Bast R - Search Results

1

4-HPR modulates gene expression in ovarian cells.

Brewer M, Kirkpatrick ND, Wharton JT, Wang J, Hatch K, Auersperg N, Utzinger U, Gershenson D, Bast R, Zou C. Brewer M, et al. Among authors: bast r. Int J Cancer. 2006 Sep 1;119(5):1005-13. doi: 10.1002/ijc.21797. Int J Cancer. 2006. PMID: 16570282 Free article.

2

Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer.

Olt G, Berchuck A, Soisson AP, Boyer CM, Bast RC Jr. Olt G, et al. Among authors: bast rc jr. Cancer. 1992 Oct 15;70(8):2137-42. doi: 10.1002/1097-0142(19921015)70:8<2137::aid-cncr2820700821>3.0.co;2-w. Cancer. 1992. PMID: 1394043

3

Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta.

Havrilesky LJ, Hurteau JA, Whitaker RS, Elbendary A, Wu S, Rodriguez GC, Bast RC Jr, Berchuck A. Havrilesky LJ, et al. Among authors: bast rc jr. Cancer Res. 1995 Feb 15;55(4):944-8. Cancer Res. 1995. PMID: 7531618

4

Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.

Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RC Jr, Iglehart JD, Marks JR. Elbendary A, et al. Among authors: bast rc jr. Cell Growth Differ. 1994 Dec;5(12):1301-7. Cell Growth Differ. 1994. PMID: 7696178

5

Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer.

Lukes AS, Kohler MF, Pieper CF, Kerns BJ, Bentley R, Rodriguez GC, Soper JT, Clarke-Pearson DL, Bast RC Jr, Berchuck A. Lukes AS, et al. Among authors: bast rc jr. Cancer. 1994 May 1;73(9):2380-5. doi: 10.1002/1097-0142(19940501)73:9<2380::aid-cncr2820730922>3.0.co;2-g. Cancer. 1994. PMID: 7909491

6

Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites.

Hurteau J, Rodriguez GC, Whitaker RS, Shah S, Mills G, Bast RC, Berchuck A. Hurteau J, et al. Among authors: bast rc. Cancer. 1994 Jul 1;74(1):93-9. doi: 10.1002/1097-0142(19940701)74:1<93::aid-cncr2820740117>3.0.co;2-p. Cancer. 1994. PMID: 8004589

7

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.

Kohler MF, Marks JR, Wiseman RW, Jacobs IJ, Davidoff AM, Clarke-Pearson DL, Soper JT, Bast RC Jr, Berchuck A. Kohler MF, et al. Among authors: bast rc jr. J Natl Cancer Inst. 1993 Sep 15;85(18):1513-9. doi: 10.1093/jnci/85.18.1513. J Natl Cancer Inst. 1993. PMID: 8360934

8

Growth regulation and transformation of ovarian epithelium.

Berchuck A, Kohler MF, Boente MP, Rodriguez GC, Whitaker RS, Bast RC Jr. Berchuck A, et al. Among authors: bast rc jr. Cancer. 1993 Jan 15;71(2 Suppl):545-51. doi: 10.1002/cncr.2820710209. Cancer. 1993. PMID: 8420675 Review.

9

Expression of cell regulatory proteins in ovarian borderline tumors.

van Haaften-Day C, Russell P, Boyer CM, Kerns BJ, Wiener JR, Jensen DN, Bast RC Jr, Hacker NF. van Haaften-Day C, et al. Among authors: bast rc jr. Cancer. 1996 May 15;77(10):2092-8. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2092::AID-CNCR19>3.0.CO;2-Q. Cancer. 1996. PMID: 8640675

10

A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer.

Gershenson DM, Burke TW, Morris M, Bast RC, Guaspari A, Hohneker J, Wharton JT. Gershenson DM, et al. Among authors: bast rc. Gynecol Oncol. 1998 Sep;70(3):404-9. doi: 10.1006/gyno.1998.5130. Gynecol Oncol. 1998. PMID: 9790795 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

635 results

Search Page